[HTML][HTML] A cost-effectiveness analysis of remdesivir for the treatment of hospitalized patients with COVID-19 in England and Wales
R Rafia, M Martyn-St James, S Harnan, A Metry… - Value in Health, 2022 - Elsevier
Objectives COVID-19 is associated with significant morbidity and mortality. This study aims
to synthesize evidence to assess the cost-effectiveness of remdesivir (RDV) for the treatment …
to synthesize evidence to assess the cost-effectiveness of remdesivir (RDV) for the treatment …
A Cost-Effectiveness Analysis of Remdesivir for the Treatment of Hospitalized Patients With COVID-19 in England and Wales.
R Rafia, M Martyn-St James, S Harnan… - Value in Health: the …, 2022 - europepmc.org
Objectives COVID-19 is associated with significant morbidity and mortality. This study aims
to synthesize evidence to assess the cost-effectiveness of remdesivir (RDV) for the treatment …
to synthesize evidence to assess the cost-effectiveness of remdesivir (RDV) for the treatment …
A Cost-Effectiveness Analysis of Remdesivir for the Treatment of Hospitalized Patients With COVID-19 in England and Wales
R Rafia, M Martyn-St James… - Value in health: the …, 2022 - pubmed.ncbi.nlm.nih.gov
Objectives COVID-19 is associated with significant morbidity and mortality. This study aims
to synthesize evidence to assess the cost-effectiveness of remdesivir (RDV) for the treatment …
to synthesize evidence to assess the cost-effectiveness of remdesivir (RDV) for the treatment …
A Cost-Effectiveness Analysis of Remdesivir for the Treatment of Hospitalized Patients With COVID-19 in England and Wales
R Rafia, M Martyn-St James, S Harnan… - Value in …, 2022 - valueinhealthjournal.com
Objectives COVID-19 is associated with significant morbidity and mortality. This study aims
to synthesize evidence to assess the cost-effectiveness of remdesivir (RDV) for the treatment …
to synthesize evidence to assess the cost-effectiveness of remdesivir (RDV) for the treatment …
A cost-effectiveness analysis of remdesivir for the treatment of hospitalised patients with COVID-19 in England and Wales
R Rafia, MS James, S Harnan, A Metry… - Value in …, 2022 - eprints.whiterose.ac.uk
Objectives: COVID-19 is associated with significant morbidity and mortality. This study aims
to synthesize evidence to assess the cost-effectiveness of remdesivir (RDV) for the treatment …
to synthesize evidence to assess the cost-effectiveness of remdesivir (RDV) for the treatment …
[HTML][HTML] A Cost-Effectiveness Analysis of Remdesivir for the Treatment of Hospitalized Patients With COVID-19 in England and Wales
R Rafia, M Martyn-St James, S Harnan, A Metry… - Value in …, 2022 - ncbi.nlm.nih.gov
Objectives COVID-19 is associated with significant morbidity and mortality. This study aims
to synthesize evidence to assess the cost-effectiveness of remdesivir (RDV) for the treatment …
to synthesize evidence to assess the cost-effectiveness of remdesivir (RDV) for the treatment …
A Cost-Effectiveness Analysis of Remdesivir for the Treatment of Hospitalized Patients With COVID-19 in England and Wales.
R Rafia, M Martyn-St James, S Harnan… - Value in Health: the …, 2022 - europepmc.org
Objectives COVID-19 is associated with significant morbidity and mortality. This study aims
to synthesize evidence to assess the cost-effectiveness of remdesivir (RDV) for the treatment …
to synthesize evidence to assess the cost-effectiveness of remdesivir (RDV) for the treatment …